AB SCIENCE SA (AB.PA) Stock Price & Overview
EPA:AB • FR0010557264
The current stock price of AB.PA is 1.242 EUR. Today AB.PA is down by -0.32%. In the past month the price decreased by -6.32%. In the past year, price decreased by -8.38%.
AB.PA Key Statistics
- Market Cap
- 82.196M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.15
- Dividend Yield
- N/A
AB.PA Stock Performance
AB.PA Stock Chart
AB.PA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to AB.PA. When comparing the yearly performance of all stocks, AB.PA is a bad performer in the overall market: 77.46% of all stocks are doing better.
AB.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AB.PA. AB.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
AB.PA Earnings
AB.PA Forecast & Estimates
9 analysts have analysed AB.PA and the average price target is 3.79 EUR. This implies a price increase of 205.51% is expected in the next year compared to the current price of 1.242.
For the next year, analysts expect an EPS growth of 65.85% and a revenue growth -3% for AB.PA
AB.PA Groups
Sector & Classification
AB.PA Financial Highlights
Over the last trailing twelve months AB.PA reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS decreased by -23.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -40.25% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AB.PA Ownership
AB.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SNW | SANOFI | 9.03 | 184.842B | ||
| SAN | SANOFI | 9.03 | 184.817B | ||
| 1SAN | SANOFI | 9.02 | 184.6B | ||
| UNC | UCB SA | 24.6 | 49.211B | ||
| UCB | UCB SA | 24.73 | 49.133B | ||
| 1MRK | MERCK KGAA | 12.9 | 48.217B | ||
| MRK | MERCK KGAA | 13.18 | 47.587B | ||
| BAYN | BAYER AG-REG | 8.38 | 38.442B | ||
| 1BAYN | BAYER AG-REG | 8.36 | 38.422B | ||
| IPN | IPSEN | 12.65 | 12.848B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.08 | 9.733B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.681B | ||
| VIRP | VIRBAC SA | 15.36 | 2.806B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About AB.PA
Company Profile
AB Science SA operates as a pharmaceutical company, which engages in the research, development, and marketing of synthetic therapeutic molecules for pathologies with high medical need, in diseases of the central nervous system, cancers, and inflammatory diseases. The company is headquartered in Paris, Ile-De-France and currently employs 37 full-time employees. The company went IPO on 2010-04-21. The company is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The firm is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.
Company Info
IPO: 2010-04-21
AB SCIENCE SA
3, avenue George V
Paris ILE-DE-FRANCE FR
Employees: 40
Phone: 33147200014
AB SCIENCE SA / AB.PA FAQ
What does AB do?
AB Science SA operates as a pharmaceutical company, which engages in the research, development, and marketing of synthetic therapeutic molecules for pathologies with high medical need, in diseases of the central nervous system, cancers, and inflammatory diseases. The company is headquartered in Paris, Ile-De-France and currently employs 37 full-time employees. The company went IPO on 2010-04-21. The company is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The firm is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.
What is the current price of AB stock?
The current stock price of AB.PA is 1.242 EUR. The price decreased by -0.32% in the last trading session.
Does AB stock pay dividends?
AB.PA does not pay a dividend.
What is the ChartMill rating of AB SCIENCE SA stock?
AB.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the analyst forecast for AB.PA stock?
9 analysts have analysed AB.PA and the average price target is 3.79 EUR. This implies a price increase of 205.51% is expected in the next year compared to the current price of 1.242.
What is AB SCIENCE SA worth?
AB SCIENCE SA (AB.PA) has a market capitalization of 82.20M EUR. This makes AB.PA a Micro Cap stock.